AMGN Snapshot
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Market Capitalization$130,165,137,000
Price to Sales5.05
Earnings per Share$9.7000
PE Ratio23.82
Most Recent Close$228.9000
52 Week High$268.39
52 Week Low$198.64
50-Day Moving Average$216.56
200-Day Moving Average$228.72
All data are from Alpha Vantage as of today. For more infomation on AMGN see Stock Dividend, Valuation, Price and Financial Data for Investors